<SEC-DOCUMENT>0001193125-26-336762.txt : 20260806
<SEC-HEADER>0001193125-26-336762.hdr.sgml : 20260806
<ACCEPTANCE-DATETIME>20260806073516
ACCESSION NUMBER:		0001193125-26-336762
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20260806
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260806
DATE AS OF CHANGE:		20260806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Climb Bio, Inc.
		CENTRAL INDEX KEY:			0001768446
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				832273741
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40708
		FILM NUMBER:		261246024

	BUSINESS ADDRESS:	
		STREET 1:		20 WILLIAM STREET
		STREET 2:		SUITE 145
		CITY:			WELLESLEY HILLS
		STATE:			MA
		ZIP:			02481
		BUSINESS PHONE:		1-866-857-2596

	MAIL ADDRESS:	
		STREET 1:		20 WILLIAM STREET
		STREET 2:		SUITE 145
		CITY:			WELLESLEY HILLS
		STATE:			MA
		ZIP:			02481

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eliem Therapeutics, Inc.
		DATE OF NAME CHANGE:	20190219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>clym-20260806.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-08-05T19:50:53.0948+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:clym="http://climbbio.com/20260806" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_f5059046-39a9-41b6-878a-e8fd5cf908a7" name="dei:EntityCentralIndexKey" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5">0001768446</ix:nonNumeric><ix:nonNumeric id="F_36c51d5b-56b4-4ae0-bb04-e99e2800ea5b" name="dei:AmendmentFlag" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="clym-20260806.xsd"/></ix:references><ix:resources><xbrli:context id="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-08-06</xbrli:startDate><xbrli:endDate>2026-08-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9781d5bc-4e8a-4d66-842c-0f5d01334a75" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_0ca131c7-54c8-4eb2-9c18-bfe6aa725455" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">August 06, 2026</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2cf79376-c37f-47b7-90e5-5254bb61b804" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Climb Bio, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f71cc1f8-0806-4e73-815e-ccb7dca9add8" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_fb6a3318-e52c-429f-aa1e-8e031cab83e7" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-40708</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_43ae38f2-2b19-4c9c-b550-2bca37643d2b" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">83-2273741</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_831055e1-160c-4258-8676-54c89a80775f" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">20 William Street</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_323de6b9-b0a0-42b8-9a4f-bd1aa71c26a9" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 145</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5c933b77-fa37-458b-8903-4c3cba40321b" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Wellesley Hills</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_ebf11f70-8a7f-4634-a6b5-81bbe8931a0f" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2ef6e0f3-046e-4e6b-b166-917e299ba66b" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02481</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_8975b4e0-3a1e-44e5-966c-a635a1366791" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(866)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_9e6d03b0-e177-4ec9-b952-b6961f896608" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">857-2596</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_811cb093-12fb-4786-9707-aec43f96fd4a" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18174edc-269c-4423-acc7-ed909b97b735" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a3d88b9-705b-43db-b46f-8c1bbd40aaf5" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1f814072-1a7d-4200-bc21-1e3c19c92417" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f9c5ddaa-230d-4b95-a42e-9b4c9c33fe3f" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_dd4b0c84-7c88-4029-ba6f-23035a4e4e3b" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CLYM</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9ac36a08-2f02-48c9-a352-4f82e5db7349" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_5f0592f8-a08f-4954-966b-10fd8434b4cc" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_333ca0ed-a0f2-4f9f-87fd-e9a7aad86761" contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 6, 2026, Climb Bio, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, whether filed before or after the date hereof and regardless of any general incorporation language in such filing.</span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) </span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.08%;box-sizing:content-box;"/>
     <td style="width:2.02%;box-sizing:content-box;"/>
     <td style="width:90.9%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="clym-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press release of Climb Bio, Inc., dated August 6, 2026</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;104</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Climb Bio, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 6, 2026</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Aoife Brennan</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Aoife Brennan, M.B., Ch.B.<br/></span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>clym-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-08-05T19:50:53.1382+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:86.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">        Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img109660168_0.jpg" alt="img109660168_0.jpg" style="width:304px;height:89px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CLYM116 Phase 1 data in healthy volunteers to be presented at R&amp;D Spotlight Event on September 3, 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipate CLYM116 Phase 2 trial in IgA nephropathy to initiate dosing in Q3 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Budoprutug clinical programs continue to advance, with data expected from pMN, ITP, and SLE studies in Q4 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing extends cash runway into the second half of 2028</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WELLESLEY HILLS, Mass., August 6, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today reported financial results for the second quarter ended June 30, 2026, and provided business updates.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;2026 is proving to be a defining year for Climb Bio, and I am thrilled by the team&#x2019;s execution ,&#x201d; said Aoife Brennan, M.B., Ch.B., President and Chief Executive Officer of Climb Bio. &#x201c;We achieved important milestones for both budoprutug and CLYM116 over the past few months, and that momentum continues into the second half of the year with further data readouts across all four of our ongoing trials and the initiation of a Phase 2 trial of CLYM116 in IgAN patients. Currently at the forefront, I look forward to sharing initial Phase 1 data from CLYM116 in our September R&amp;D Spotlight, where we will further highlight its potential as a best-in-class anti-APRIL antibody and provide additional details on our development strategy. With our continued progress across our pipeline, and supported by our strengthened balance sheet, we are well positioned to continue to execute on our strategic priorities and rapidly advance both programs toward pivotal development, setting the stage for what we believe will be an exciting 2027 for Climb.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLYM116 Program Updates and Anticipated Milestones</font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLYM116 R&amp;D Spotlight to be held on September 3, 2026. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will host a webcast to review the initial Phase 1 PK/PD data and development plans for CLYM116 for the treatment of IgA nephropathy (IgAN). </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Presented CLYM116 initial Phase 1 safety data and translational PK/PD modeling at the European Renal Association (ERA) Congress in June 2026</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Clinical data demonstrated a favorable initial safety profile and supported continued development of CLYM116 for IgA nephropathy (IgAN). </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipate additional Phase 1 data at a medical meeting in the fourth quarter of 2026. </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mabworks Phase 1/2 study, enrollment ongoing. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Phase 1/2 trial being conducted by the Company's partner, Beijing Mabworks Biotech Co., Ltd., is ongoing, with dosing of IgAN patients in the Phase 2 portion expected to begin in the third quarter of 2026. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipate initial Phase 1 data at an upcoming medical meeting, and initial Phase 2 data in 2027.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Budoprutug Program Updates and Anticipated Milestones</font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PrisMN Phase 2 primary membranous nephropathy (pMN) trial, enrollment ongoing.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> PrisMN is a global open-label, dose-ranging Phase 2 study designed to evaluate pharmacodynamics (including B cells, anti-PLA2R, and total immunoglobulin) and preliminary efficacy (including complete and partial remission) in pMN patients with persistent proteinuria despite optimized renin-angiotensin-aldosterone system (RAAS) inhibition, and to identify a dose for Phase 3 clinical development.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Enrollment is now ongoing in the second cohort (600 mg) and anticipate initial data, including preliminary B cell and anti-PLA2R data from low dose cohort (200mg at 12-24 weeks), at a medical meeting in the fourth quarter of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Presented initial Phase 1b data in previously treated immune thrombocytopenia (ITP) patients at European Hematology Association Congress in June 2026. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Initial safety data from the 250 mg and 500 mg cohorts demonstrated favorable safety and tolerability, and initial efficacy data from the 250 mg cohort demonstrated robust B-cell depletion, and encouraging platelet responses. These data support continued development of budoprutug across multiple autoimmune indications. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipate additional data from the 500 mg and 1000 mg cohorts in the fourth quarter of 2026. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First patient dosed in China Phase 1b/2a trial of budoprutug in systemic lupus erythematosus (SLE); Global Phase 1b SLE trial enrollment ongoing.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The global, open-label, dose-escalation Phase 1b trial of budoprutug in moderate to severe SLE is designed to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy, including B-cell depletion, autoantibody levels, and clinical activity. The parallel China Phase 1b/2a trial in SLE is anticipated to provide complementary data and will also seek to enroll SLE patients with lupus nephritis. Data from these trials are expected to provide insights into budoprutug activity and will also help to inform future development efforts for the program broadly. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipate data, including safety and biomarker data from the Global study in the fourth quarter of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Presented positive topline data for subcutaneous (SC) formulation of budoprutug at Company R&amp;D Spotlight in May 2026. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SC formulation of budoprutug was generally safe and well-tolerated and resulted in robust B-cell depletion, which was similar to the IV formulation at a matched dose. The results support the advancement of the SC formulation to a multiple dose study in autoimmune disease patients to evaluate full B-cell depleting doses and optimal dosing regimen. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Plan to initiate a multiple-dose study of the SC formulation in autoimmune patients; anticipate initial data in 2027.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Updates</font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 29, 2026, the Company completed a private placement financing, generating approximately $110 million in aggregated gross proceeds.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Company's financing supports the Company&#x2019;s continued advancement of its clinical pipeline, including preparation for later-stage development, and extends its cash runway into the second half of 2028. </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2026, the Company appointed Breanna O'Reilly, Ph.D., to its Board of Directors. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. O&#x2019;Reilly, of RA Capital Management, brings deep scientific expertise and a valuable investor perspective to support the Company&#x2019;s clinical development strategy and long-term growth objectives. Dr. O&#x2019;Reilly fills the seat previously held by Dr. Andrew Levin, Advisor at RA Capital.   </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Second Quarter Financial Results and Guidance</font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash Position: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and marketable securities were $239.2 million as of June 30, 2026. Based on its current operating plan, the Company expects this balance to fund operations into the second half of 2028.</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and Development (R&amp;D) Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R&amp;D expenses were $9.7 million for the three months ended June 30, 2026, compared to $6.6 million for the comparable period in 2025.</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and Administrative (G&amp;A) Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">G&amp;A expenses were $5.6 million for the three months ended June 30, 2026, compared to $4.1 million for the comparable period in 2025.</font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.095052533442276%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Income, Net: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income, net was $1.9 million for the three months ended June 30, 2026, compared to $2.0 million for the comparable period in 2025.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About Climb Bio, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>Climb Bio, Inc. is a clinical-stage biotechnology company with a mission to deliver high impact, disease-modifying medicines for individuals living with immune-mediated diseases, including those affecting kidney health. The Company&#x2019;s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody being developed for IgA nephropathy. For more information, please visit </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">climbbio.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About Budoprutug</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>Budoprutug is a clinical-stage, anti-CD19 monoclonal antibody with the potential to address a broad range of B-cell mediated, immune-driven diseases. Designed with enhanced effector function and low picomolar affinity, budoprutug targets and depletes CD19-expressing B cells, including plasmablasts and certain plasma cells, key sources of pathogenic autoantibodies. Early clinical data suggest budoprutug may offer durable B-cell depletion, rapid reductions in autoantibodies, and clinical remission in primary membranous nephropathy (pMN). Budoprutug is being evaluated in clinical trials for pMN, immune thrombocytopenia (ITP), and systemic lupus erythematosus (SLE). A subcutaneous formulation is also in development to enable broader patient access. Budoprutug has been granted Orphan Drug Designation and Fast Track Designation by the FDA for the treatment of pMN.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About CLYM116</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLYM116 is a clinical-stage monoclonal antibody targeting APRIL (A Proliferation-Inducing Ligand), a key driver of pathogenic B-cell activity in autoimmune diseases. CLYM116 employs a novel pH-dependent bind-and-release &#x2018;sweeper&#x2019; mechanism to potently block APRIL signaling, promote lysosomal degradation of APRIL, and recycle the antibody to extend its half-life. This differentiated design offers the potential for rapid, deep, and durable inhibition of APRIL with a favorable safety profile and less frequent dosing. CLYM116 is being advanced for the treatment of IgA nephropathy (IgAN) and may also have broader utility across other B-cell mediated diseases where APRIL plays a critical role.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This press release contains &#x201c;forward-looking statements,&#x201d; including without limitation statements regarding: future expectations, plans and prospects for Climb Bio; expectations regarding the therapeutic benefits, clinical potential and clinical development of CLYM116; the anticipated timelines for announcing data from Climb Bio&#x2019;s ongoing and planned clinical trials; the anticipated timelines for enrolling patients in planned clinical trials; expectations regarding cash runway; Climb Bio&#x2019;s expectations regarding the anticipated benefits of Climb Bio&#x2019;s technology transfer and exclusive license agreement with Mabworks; and other statements containing the words &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;expect,&#x201d; &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;potential,&#x201d; should,&#x201d; &#x201c;suggest,&#x201d; &#x201c;target,&#x201d; &#x201c;will,&#x201d; and similar expressions. Forward-looking statements are based on management&#x2019;s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in, or implied by, such forward-looking statements. Climb Bio may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. These risks and uncertainties include, but are not limited to, important risks and uncertainties associated with: the ability of Climb Bio to timely and successfully achieve or recognize the anticipated benefits of its technology transfer and exclusive license agreement with Mabworks; Climb Bio&#x2019;s ability to advance budoprutug and CLYM116 on the timelines expected or at all and to obtain and maintain necessary approvals from the U.S. Food and Drug Administration and other regulatory authorities; obtaining and maintaining the necessary approvals from investigational review boards at clinical trial sites and independent data safety monitoring boards; replicating in clinical trials positive results found in early-stage clinical trials or nonclinical studies; competing successfully with other companies that are seeking to develop treatments for primary membranous nephropathy, immune thrombocytopenia, systemic lupus erythematosus, IgA nephropathy and other immune-mediated diseases; maintaining or protecting intellectual property rights related to budoprutug, CLYM116 and/or its other product candidates; managing expenses; changes in applicable laws or regulation; the possibility that Climb Bio may be adversely affected by other economic, business and/or competitive factors; and raising the substantial additional capital needed, on the timeline necessary, to continue development of budoprutug, CLYM116 and any other product candidates Climb Bio may develop. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Climb Bio&#x2019;s actual results to differ materially from those contained in the forward-looking statements, see the &#x201c;Risk Factors&#x201d; section, as well as discussions of potential risks, uncertainties and other important factors, in Climb Bio&#x2019;s most recent filings with the U.S. Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Climb Bio&#x2019;s views as of the date hereof and should not be relied upon as representing Climb Bio&#x2019;s views as of any date subsequent to the date hereof. Climb Bio anticipates that subsequent events and developments will cause Climb Bio&#x2019;s views to change. However, while Climb Bio may elect to update these forward-looking statements at some point in the future, Climb Bio specifically disclaims any obligation to do so, except as required by law.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investors and Media</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Carlo Tanzi, Ph.D.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Kendall Investor Relations</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ctanzi@kendallir.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Climb Bio, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheets</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:60%;box-sizing:content-box;"></td>
     <td style="width:2%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:16.259999999999998%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.96%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:15.780000000000001%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June 30, 2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and marketable securities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">239,221</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">160,652</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,073</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,092</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">246,294</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">167,744</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,747</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,269</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">239,547</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">160,475</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">246,294</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">167,744</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Operations</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except per share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(unaudited)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:44.08%;box-sizing:content-box;"></td>
     <td style="width:1.32%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:11.020000000000001%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.44%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:11.020000000000001%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.32%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:10.18%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.44%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:10.18%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended June 30,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Six Months Ended June 30,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,714</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,575</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,087</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,902</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,645</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,102</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,483</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,793</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">15,359</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">10,677</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">30,570</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">33,695</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(15,359</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(10,677</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(30,570</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(33,695</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,861</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,011</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,350</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,248</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(13,498</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(8,666</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(27,220</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(29,447</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.18</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.13</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.38</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.44</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img109660168_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109660168_0.jpg
M_]C_X  02D9)1@ ! @$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #S SP# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML]6U/3I%FL;Z[M)$QM>VN)K=A@Y'S0O&3@@$$G([5[AX0_:4^)OA<I#/J_\
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M[E]'%8.I*CAJ?B#D&"]AB\*W[GM^(LAPT71Q5':5;&9)2P]:FKM95B6W*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML;B4M=;7AAJ3<H8:@GRTX7E+FJSJU)E%%%?@!]H%%%.5'<X16<^BJ6/Y $T
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M?"3_ +^^(_\ Y04?\/F/^"7O_1YWPD_[^^(__E!0!^F]%?F2/^"R_P#P2])
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M+B]^)OA>PO)=(UFU2\LGN;*XNUFM9FAD4R0R@/&QVL P('H7_$-9_P %.O\
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MEGN;FX\'Z-+/<3RN2\DTTKM))(Q+.[,S$DFO6:\?_9Z_Y(#\#O\ LC_PS_\
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M#'Q9IMEJ7AKX3:;>)'<Z=J&JZ1=+<VNK>/9X&2X#7T<EKX9#HMK;MJZ?:[,
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MV45__35IU 'Y55_I'?\ !N3_ ,HK?@]_V/'Q@_\ 5AZW7^;C7^D=_P &Y/\
MRBM^#W_8\?&#_P!6'K= '[I4444 ?PZ?\'8__)=_V3O^R2>,O_4Q6OY*J_K5
M_P"#L?\ Y+O^R=_V23QE_P"IBM?R54 =A>> _%%CX'T7XC3Z7,/!^O>(-8\+
MZ?K" O;G7=#L]-O[W3IV Q!<&SU2WN+='(:XB2Y>,$6\A7OOV;?CEXN_9I^/
M7PG^//@:_N]/\2_"_P :Z-XIM'LI%BFO+*UN!%K>BN[?+]D\0:%/J6A:@A*^
M;8:C<Q!T+[U_<W]BS]CQ_P!KK_@B)^V'%X?T^*[^)7P0^-UM\:? /[II+F\?
MPCX'23Q9H%L$_>/<Z[X/N-<M--A4A9-9_LWS,QAL?SB4 ?["GP8^*?AKXW_"
M;X<_%_P=>V^H^&/B1X.T'QAHUY:2"6WEL];T^"]58Y 3N$+R/ V3N#1L&PP(
MKA/VLOVAO#7[*/[.'QB_:&\5I'<:5\+/ ^L^)H]/DF^SC6M8@MS#X?T!)L@Q
MRZ]KLVGZ1"ZY=9+Q2BLP /\ /1_P:_\ [8:?$?\ 9]\>?LF>*M;DN?%GP3U5
M_%'@FUOIWEN)_AUXGN2;BUM))F):WT'7VE@BLX2PL[2\A8)'$RBO#_\ @Z<_
M;%NM*T#X1?L3^$]9,#>)VA^+WQ9M+2X02SZ)IEU<V'@'1-2B!9FL+_6X-2\0
M")A&QO?#>FS E%PX!_'-\3OB-XM^+_Q%\;_%/QYJ<FL^,_B%XIUSQCXGU27A
MKS6O$&HW&IZA*J#Y8HOM%RZP0IB."%8XHP$10+D_PL\9VOPLL/C)=:7);^!-
M4\:7/@+3-4F#Q_VCK]CI*ZS?162N@6YM[.U>-+F>)V6&YD6!\2$@<1IFFW^L
MZEI^CZ7:3W^IZK?6FFZ;8VL;375[?WUQ':V=I;0H"\UQ<W$L<,,2 M)*ZHH)
M8"OZ8O\ @L1^RG%^QE_P36_X)N?!"YALU\56.I^-_$_Q NK%2(+WQSXKT33=
M9UYU+HDC);3W LD,FYOW#'<0PP ?S'U_;)_P::_\D\_:\_['+X=?^F76:_B;
MK^V3_@TU_P"2>?M>?]CE\.O_ $RZS0!_7Y1110!_'_\ \':O_(A?L1?]C9\=
M_P#TT_"FOXGZ_M@_X.U?^1"_8B_[&SX[_P#II^%-?Q/T ?UU_P#!IE_R5K]L
M7_LGGPM_]23Q17]NM?YSO_!!;_@HI^SG_P $]O'G[0_B']H;4/$^GZ?\2?"/
M@?1O#3>&O#E[XBDDO-!UC7+W4%NHK)6:V18+^W,;R85V+*,E37]+?_$2W_P3
M._Z&/XJ_^&RU[_XB@#^@>OP:_P"#D*[\-VW_  2^^(,.NM;#4+WXD_"^V\*+
M.4$SZ^NN2W$GV0,"QF70H-:9_+PWD"7<0A;/E?C/_@YY_P"">V@Z9/=>%=)^
M,OCG4DC)M],LO!J:'YTNUBJR7FOWMC!$FX!6;YR,Y (R1_*+_P %3O\ @K5\
M7O\ @I;XRT2UU'21\./@=X%N[F[\"_"ZSOVOV?5+B(VLWBOQ9J"I%'J?B":T
MW06T440LM'M[BYM;1KCS9+J4 _)*OTZ_X(U_#O6OB9_P4N_9*T31+6>Y?2/B
M?IOC/4VAC>3[)H7@J"X\3:S>RE1B.*VL-,F8O(R(9#''NWR*K?&7P/\ V;_C
MM^TEXLTWP3\#?A5XV^)GB+4[N*SBM?"N@W^I6]LTCHCW&IZA#";#2[&U5Q->
MWVH7-M:6=NK3W$T<:EJ_T!_^"*G_  1[3_@G?X7U[XI?&&[T3Q)^TM\1=)@T
MG4CI)BU#1_AKX8,D-W/X6T35,,E_J=_=PPOKVL6>VWF%LEG93S63R;P#][**
M** (I_\ 43?]<I/_ $!J_P A[]J;_DYW]HG_ ++I\6/_ %/=>K_7AG_U$W_7
M*3_T!J_R'OVIO^3G?VB?^RZ?%C_U/=>H _U$O^"<7_)AG[(__9!?AU_ZC]I7
MVI7X_P#[ O[=7[%_A#]BK]EWPQXI_:J^ /A[Q'H/P4\!Z7K6AZQ\5?!NGZKI
M.I6>AVT-W8:C876KQ7-G=VTJM'-;SQI)&ZE64$5]=?\ #PW]A'_H\+]F_P#\
M/#X&_P#EU0!]C45\6WW_  4=_8$TRVDO-0_;+_9IM+:(9>:?XR>!40>@R=:R
MS,>%106=B%4%B!7XV_MT_P#!R?\ LL_"'PQXF\(_LESW'Q\^+CV]WI>D^)(=
M-OM/^%WAS4I8FCBUB;5]0BM)/%L-F76XMK?0([FPO)T6";4(X_-P ?AC_P '
M.7Q-\*>.?^"AVE>%O#6HV>J7GPM^"?@_PIXODM7#OIGBF_UKQ/XDET*ZP.+B
MRT35]#O7&3M_M3R\!D;/Z]_\&I?POUW0OV;?VB_BSJ-G<6FC^/\ XL:1X8\/
MRW$,L2ZG!X&\-P3:AJ%DSJ([FS34?$T^F&XA+*+[3[VV9A);.J_S;_LF_P#!
M/G]M;_@K!\?=>\;_ -D:_#HWC'Q/<^*?BS^T!XVT^\LO".E?VGJ"-J#6-W<I
M FOZWLF\O1_"^B/<78M+<N(H--L;B>'_ $@/V6_V</AY^R1\!/AK^SU\+K62
M#P=\-?#T&CVES<JBW^LZA+)+?:YXAU,Q_(VI^(-9NK[5[\J2HN;R14)15- '
MO]%%% '&?$?_ ))YX\_[$SQ1_P"F.^K_ "#/$G_)2M=_['34O_3U-7^OG\1_
M^2>>//\ L3/%'_ICOJ_R#/$G_)2M=_['34O_ $]34 ?ZXW[/7_) ?@=_V1_X
M9_\ J%Z)7L%>/_L]?\D!^!W_ &1_X9_^H7HE>P4 %?R:_P#!T]^U=JW@OX-?
M!?\ 9)\+ZBUD_P 8-=O_ (B_$86\C)<7?@_P');VWAS0IU!VMIVJ^*M276;@
M, YNO"=@JGRVF5OZRJ_SG_\ @Y5^*4WCW_@IAXC\(BX9[3X._"GX<>!4M03Y
M4%[JMA>?$*[GV\XGN;;QIIR2L#\T5M;C *Y(!B?\&]O[%>E_M6_MMV/C;QK8
M"_\ AO\ LXZ=:?$G6+">%)K/6O%DMV]IX(T>[2:)HY+-;^&\UBZ\N1)XY-*L
MU!V3L#_H]@ # & . !T ]*_ED_X-5OA9%H'[)_QS^*]W8I%J7C_XS?V%IU\%
M/F7/AOPAX9T=$1G9%.(]>U'6E"(SH-@8G>Y5/ZFZ "BBB@ HHHH _FJ_X.6?
MV+]+^-'[)=G^T[X;T"VD^)'[.=W%-KFL6\,:7]Y\*=:NTAUJUO[G!DGL?#^I
MS0:M:0$?N9+R]D#(CR&OY0/^",_[4<G[*'_!0GX"^,K_ %-=+\%^-?$UK\)_
MB%-/*8K"'PI\0KFWT&;4M1(ZVF@:C<:?K[Y#>6=,$JKO12/]*S]H[P-I7Q+^
M /QH\ ZW90ZCIGBSX8>-]%N;.XC$L,QN_#VH+;[HV!5C'<B&5,@X>-3CBO\
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M?(D-G%XWBO8-9^'U_<2/C]ZU[#JWANSCW*)+CQ2H :3RU(!_HWT444 %%%%
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ML;B S0:A?:5=);>"O#R.K8@N]0\220ZNDDL4L+V'AW4H"$EEAD3]O?\ @[%
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ML5O-=)%'-)'(D;,R,!ZY_P ,+?MM?]&>?M2?^(__ !7_ /F3K^C_ /X-,_\
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M7=F+ZT7P].+:Y\F13)")9 C' =NM>B_\0RG_  4J_N_ S_PY=Y_\S%?VX_\
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MZ/\ P<F?L9W7[0W[&5A\=O"-A)>>/OV6M8O/%EU;VT1DGU3X7>)([73O'=N
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M99?#VH232V^MZ4(&$T>IQWEC;^H_\$AO^"YWCC]@Z.U^!_QTL==^*/[,5S=
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M]I>']!O-+T?2O#.DZO!&\L=MJJV^GWFI7< <O"-3BMY@DL+J/VWHHH ****
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MI)&^2?Q)<:3#&HVG)=UQCU(%?ZL%% '^?7^SO_P;&_MN_$K4=*N_C9XA\ _
M?PI-)!+J1GU ^,O%\5KO5KFVAT/26M["&^:(.D,L^L26\4K))*DJ*T3?V(?L
M#_\ !-/]F?\ X)W>"[[P]\$O#]U?>+?$5K:0>-_BCXI>WO\ QQXN^R'S8X+J
M]A@@M],TA+@M<0:'I,%IIL<VV5X99U$U?H)10 4444 ,D7>CIG&]&7/IN!&?
MUK_,-_X*.?\ !-G]L'X'_M:_&V&[^!OQ(\9>%?&?Q,\;>-? OC3P'X/U[QEH
M/B3PSXI\0ZAKFG727'AVPU%["\MHK[[#J5AJ$=K/;:A:W4:+-;B&YF_T]:*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>clym-20260806.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-08-05T19:50:53.4704+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://climbbio.com/20260806" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:clym="http://climbbio.com/20260806" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" namespace="http://fasb.org/us-gaap/2026"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" namespace="http://xbrl.sec.gov/dei/2026"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="clym-20260806.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 06, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  06,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Climb Bio, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001768446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2273741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20 William Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wellesley Hills<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">857-2596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLYM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="clym-20260806.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="clym-20260806.htm">clym-20260806.htm</File>
    <File>clym-20260806.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "clym-20260806.htm": {
   "nsprefix": "clym",
   "nsuri": "http://climbbio.com/20260806",
   "dts": {
    "inline": {
     "local": [
      "clym-20260806.htm"
     ]
    },
    "schema": {
     "local": [
      "clym-20260806.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 24
   },
   "report": {
    "R1": {
     "role": "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "clym-20260806.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "clym-20260806.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://climbbio.com/20260806/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-26-336762-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-336762-xbrl.zip
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ML!;TG:8R262??%(I3X7B"3D?]+H#PQ0-LI\DY RK%>1,%C*_DE&C:K1= CP
M)FGQ?FMDZ-=6(\LOFT80!,T;++-5%6K=A'D2J6%9?-0E3<;<9O5QK&@YL:A3
M%2U'BZJQ 8R6MIH QQ*F)@?E ?+?OE,</X>\&!:_N5=^;'[X=5!4W3S4KH'#
MP"7'%1\43[/T!%8^5V)RM:C,FV6_*YM0D*95R>&H"C5I3# #H_GGE\_GHBT[
MG-Z=>B3O0+^0HG&9737A0Q,18E!0)/W.L*1(5"<,5::Q$$LQG[FW<RXIM#(V
MF$&KMU-NECE/BSC+.QIQ$2(.HJQEC+0S&0K?:\0T*3.IX6Y]^('LM26/X"_9
M*U69R \^_6VO6?W$EQU9<DU?5/[54U?OMPZRM 2JHQ< X2TBJJ?W6Z6\*9L:
M:9O8:+-N=2_,HCXIRGXBWV]U>80TW_*[-[L=GE^JM,5[9?8WU>EF.0"\W/T/
M@#Z2-RVV2Z]E^$V5%-NEA?J/I#SZ=Z\H6P9C?]_M9H7"N;1RF7!D%+M;>K21
MNAIT%JFBF_ ^8@M^W5,W+1R3S*N?*HIDJG_>HA-1T?NM3_^*'>8$S':I%?"
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M9LW71[,;SOH25FDR[3HBL*S0\Z!YRZ.VXX?4#YA%;6&)D-O,,HTE><1JHCV
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M,)P5=61/[^C%9BB[Z^XQA^Z>=?%3/NU.@3Z@=H&9WJOT9*)=)6U>8>C PTM
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M86WSX5;'*+=K+$ BEF4)SF0$)!*CGA#$U/< W67 /<XCS$NR\!F#FD1N+H9
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MNWV4D/H._# E_ [^R[\!4$L#!!0    ( &9<!EWW-UCY/"(  (," @ /
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MS)9_4>PC6L=>:Q^PW4#KT7%"B&GWNWMRMJ:W^2:4DP%[+6.0J"CL%+L4<$G
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MA#__/U!+ 0(4 Q0    ( &9<!ETC?7. (10  ".[   1              "
M 0    !C;'EM+3(P,C8P.# V+FAT;5!+ 0(4 Q0    ( &9<!EU9'U3"O@@
M ,ID   1              "  5 4  !C;'EM+3(P,C8P.# V+GAS9%!+ 0(4
M Q0    ( &9<!EWW-UCY/"(  (," @ /              "  3T=  !C;'EM
A+65X.3E?,2YH=&U02P4&      ,  P"[    IC\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>clym-20260806_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clym-20260806.xsd" xlink:type="simple"/>
    <context id="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2026-08-06</startDate>
            <endDate>2026-08-06</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_f5059046-39a9-41b6-878a-e8fd5cf908a7">0001768446</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_36c51d5b-56b4-4ae0-bb04-e99e2800ea5b">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_9781d5bc-4e8a-4d66-842c-0f5d01334a75">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_0ca131c7-54c8-4eb2-9c18-bfe6aa725455">2026-08-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_2cf79376-c37f-47b7-90e5-5254bb61b804">Climb Bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_f71cc1f8-0806-4e73-815e-ccb7dca9add8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_fb6a3318-e52c-429f-aa1e-8e031cab83e7">001-40708</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_43ae38f2-2b19-4c9c-b550-2bca37643d2b">83-2273741</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_831055e1-160c-4258-8676-54c89a80775f">20 William Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_323de6b9-b0a0-42b8-9a4f-bd1aa71c26a9">Suite 145</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_5c933b77-fa37-458b-8903-4c3cba40321b">Wellesley Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_ebf11f70-8a7f-4634-a6b5-81bbe8931a0f">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_2ef6e0f3-046e-4e6b-b166-917e299ba66b">02481</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_8975b4e0-3a1e-44e5-966c-a635a1366791">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_9e6d03b0-e177-4ec9-b952-b6961f896608">857-2596</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_811cb093-12fb-4786-9707-aec43f96fd4a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_18174edc-269c-4423-acc7-ed909b97b735">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_2a3d88b9-705b-43db-b46f-8c1bbd40aaf5">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_1f814072-1a7d-4200-bc21-1e3c19c92417">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_f9c5ddaa-230d-4b95-a42e-9b4c9c33fe3f">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_dd4b0c84-7c88-4029-ba6f-23035a4e4e3b">CLYM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_9ac36a08-2f02-48c9-a352-4f82e5db7349">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_5f0592f8-a08f-4954-966b-10fd8434b4cc">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_03dcb314-1506-47c2-81fd-b5d9ef22a2e5"
      id="F_333ca0ed-a0f2-4f9f-87fd-e9a7aad86761">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
